Background and Objectives:Mild cognitive impairment (MCI) in isolated REM sleep behavior disorder (iRBD) is a risk factor for the subsequent neurodegeneration. We aimed to identify brain metabolism and functional connectivity changes related to MCI in patients with iRBD and the neuroimaging markers’ predictive value for phenoconversion.Methods:This is a prospective cohort study of iRBD patients with a mean follow-up of 4.2 ± 2.6 years. At baseline, the patients with iRBD and age- and sex-matched healthy controls (HC) underwent 18F-fluorodeoxyglucose (FDG)-PET and resting-state fMRI scans and performed a comprehensive neuropsychological test battery. Voxel-wise group comparisons for FDG-PET data were performed using a general linear model. Seed-based connectivity maps were computed using brain regions showing significant hypometabolism associated with MCI in iRBD patients and compared between groups. A Cox regression analysis was applied to investigate the association between brain metabolism and a risk of phenoconversion.Results:Forty patients with iRBD, including 21 with MCI (iRBD-MCI) and 19 with normal cognition (iRBD-NC), and 24 HC were included in the present study. The iRBD-MCI group revealed relative hypometabolism in the inferior parietal lobule, lateral and medial occipital, and middle and inferior temporal cortex bilaterally compared to HC and the iRBD-NC group. In seed-based connectivity analyses, the iRBD-MCI group exhibited decreased functional connectivity of the left angular gyrus with the occipital cortex. Of 40 iRBD patients, 12 patients converted to Parkinson’s disease (PD) or dementia with Lewy bodies (DLB). Hypometabolism of the occipital pole (hazard ratio [95% confidence interval] = 6.652 [1.387 – 31.987]), medial occipital (4.450 [1.143 – 17.327]), and precuneus (3.635 [1.009 – 13.093]) was associated with higher phenoconversion rate to PD/DLB.Discussion:MCI in iRBD is related to functional and metabolic changes in broad brain areas, particularly the occipital and parietal areas. Moreover, hypometabolism in these brain regions was a predictor of phenoconversion to PD or DLB. Evaluation of cognitive function and neuroimaging characteristics could be useful for risk stratification in iRBD patients.